...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: Roth Conference March 19th 11:00 AM Fireside Chat

"Today is day 35 since we last got news, and 5 days past when we were told that further financing news was "anticipated"."

Growact, perhaps those three "Report of exempt distribution excluding Schedule 1 of 45-106F1" that have appeared on SEDAR in the past month count towards the "anticipated" financing news?


New Message
Please login to post a reply